Frontiers in immunology · 2022
Development of RAG2 -/- IL2Rγ -/Y immune deficient FAH-knockout miniature pig.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Heng, Ye Weijian, Guo Jianxiong, Wang Jiaoxiang, Jiao Deling, Xu Kaixiang, Yang Chang, Chen Shuhan, Jamal Muhammad Ameen, Bai Zhongbin, Wei Taiyun, Cai Jie, Nguyen Tien Dat, Qing Yubo, Cheng Wenmin, Jia Baoyu, Li Honghui, Zhao Hong-Ye, Chen Qingfeng, Wei Hong-Jiang
Аннотация
Human hepatocyte transplantation for liver disease treatment have been hampered by the lack of quality human hepatocytes. Pigs with their large body size, longevity and physiological similarities with human are appropriate animal models for the in vivo expansion of human hepatocytes. Here we report on the generation of RAG2-/-IL2Rγ-/YFAH-/- (RGFKO) pigs via CRISPR/Cas9 system and somatic cell nuclear transfer. We showed that thymic and splenic development in RGFKO pigs was impaired. V(D)J recombination processes were also inactivated. Consequently, RGFKO pigs had significantly reduced numbers of porcine T, B and NK cells. Moreover, due to the loss of FAH, porcine hepatocytes continuously undergo apoptosis and consequently suffer hepatic damage. Thus, RGFKO pigs are both immune deficient and constantly suffer liver injury in the absence of NTBC supplementation. These results suggest that RGFKO pigs have the potential to be engrafted with human hepatocytes without immune rejection, thereby allowing for large scale expansion of human hepatocytes.